Phase III Expansion definition

Phase III Expansion means pipeline expansions, underpinned by long-term, fee-for-service agreements in Pembina's operating areas, following and expanding on certain segments of Pembina's existing Northern and Peace Pipeline systems from Taylor, British Columbia southeast to Edmonton, Alberta increasing the capacity on the system by approximately 420 mbpd;
Sample 1Sample 2Sample 3
Phase III Expansion is as generally described on Exhibit F attached hereto and shall include such changes thereto or modifications thereof as Developer may from time to time determine, provided that any such changes or modifications, whether individually or in the aggregate, do not materially and adversely affect the current operation or use of the Xxxxxxxx Rail Terminal Facility. For purposes of this Agreement, the “Phase III Expansion” shall be those development, construction and operational activities and rights conducted in, on, over, across and under the Xxxxxxxx Rail Property, it being acknowledged by the Parties that other Phase III Expansion development, construction and operational activities and rights will or may also be conducted by Developer on the Undeveloped Land and/or on any Future Acquired Land.
Sample 1Sample 2
Phase III Expansion means pipeline expansions, underpinned by long-term, fee-for-service agreements in Pembina's operating areas, following and expanding on certain segments of Pembina's existing Northern and Peace Pipeline systems from Taylor, British Columbia southeast to Edmonton, Alberta;
Sample 1Sample 2Sample 3

Examples of Phase III Expansion in a sentence

  • Funds for the WWTP Phase III Expansion construction project are encumbered in Wastewater Capital Improvement Fund Accounts 625-4812.56001 and 625-4812.56208.

  • The water demand for the Community Room was calculated using the factor 13.4 gallons per square foot per year – this factor is from the Convention Center Phase III Expansion and Expansion Hotel Project WSA (approved September 29, 2011).

  • YICT (P3) YICT Phase III and YICT Phase III Expansion are adjacent to YICT Phases I and II, and are operated by YICT (P3).

  • The construction of YICT Phase III Expansion was completed in September 2011.

  • Copy of slide presentations is attached but the following were fully discussed: KAP II: Pilot Implementation, Phase III: Expansion, Implementation Arrangements, Funding, Institutional Arrangements, and achievements with KAP.

  • The WWTP Phase III Expansion construction project will provide 3.5 million gallons per day (MGD) treatment capacity to meet capacity requirements for the City of Buda through 2040.

  • Postal code *30308 Prevailing Wage Information (corresponding to the place of employment location listed above)7.

  • Over the past five years they have developed a number of full-day teacher professional development workshops covering plate tectonics, the rock cycle, stream dynamics, and weather that provide student lessons, teaching materials, and teacher enrichment allowing their reach to extend far beyond the Museum’s walls.

  • While according the Environmental Clearance to the Phase III Expansion Project, MoEF directed (April 2008) the Company to dedicate 33 per cent of the project area for green belt development by associating the local Forest department.

  • The WWTP Phase III Expansion construction project includes site and facility improvements to meet capacity requirements of the City of Buda through 2040.


More Definitions of Phase III Expansion

Phase III Expansion means the respective expansion projects shown on Schedule 5 as the “Hearthstone A,” “Hearthstone B” and “Hearthstone C” Community Expansions, respectively. Landlord shall have no obligation to make any disbursement of Expansion Funds during the continuance of any Event of Default. Any disbursement of Expansion Funds shall be made, and all work in connection with any Expansion shall be performed, in accordance with Landlord’s reasonable and customary construction disbursement and completion requirements and pursuant to a development addendum or expansion agreement to be entered into in connection with such Approved Expansion. Upon any disbursement of Expansion Funds, Landlord’s Investment shall be increased in the amount of such disbursement in accordance with Section 2.2(a), and the amount of Minimum Rent and Additional Rent then payable shall be recalculated and reset in accordance with Section 2.1. Landlord’s commitment to make the Expansion Funds available shall be cancelled, and Landlord’s obligation to disburse any remaining Expansion Funds shall terminate, on the date that is (i) three (3) years after the date hereof with respect to the Phase I Expansion and Phase II Expansion (provided that, subject to the other terms and conditions of this Section 8.4(b), Landlord shall remain obligated to disburse such Expansion Funds as may be required to complete any approved work in connection with a Phase I Expansion or Phase II Expansion then in process), or (ii) such date determined by Landlord with respect to any approved Phase III Expansion.
Sample 1

Related to Phase III Expansion

  • Phase III means Phase I (or Phase I/II), Phase II (or Phase II/III) and Phase III clinical trials, respectively, in each case as prescribed by applicable FDA IND Regulations, or any corresponding foreign statutes, rules or regulations.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase 1 means the first implementation phase of this section, beginning June 1, 2018 and ending May 31, 2022.

  • Phase III Trial means a human Clinical Trial of the Licensed Product, which trial is designed (a) to establish that the Licensed Product is safe and efficacious for its intended use; (b) to define warnings, precautions and adverse reactions that are associated with the Licensed Product in the dosage range to be prescribed; and (c) consistent with 21 CFR § 312.21(c).

  • Phase 3 means the period commencing on the day after the Phase 2 implementation date and ending on the Phase 3 implementation date (as defined below).

  • Phase II Study means a human clinical trial, for which the primary endpoints include a determination of dose ranges and/or a preliminary determination of efficacy in patients being studied as described in 21 C.F.R. § 312.21(b) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Development Phase means the period before a vehicle type is type approved.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Phase II means the second part of the tuition incentive assistance program which provides assistance in the third and fourth year of 4-year degree programs.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Lateral expansion means a horizontal expansion of the waste boundaries of an existing MSW landfill. A lateral expansion is not a modification unless it results in an increase in the design capacity of the landfill.

  • Expansion means the addition of buildings, structures, machinery or equipment for purposes of increasing production capacity.

  • Development Project means a project for the development of land within a

  • Expansion Project has the meaning set forth in Section IV.3.a of this Agreement.

  • Phase I Trial means a clinical trial of a Licensed Product in human patients conducted primarily for the purpose of determining the safety, tolerability and preliminary activity of the Licensed Product, including, without limitation, for determining the maximum tolerated dose, or optimal dose. For purposes of this Agreement, a Phase I trial shall specifically exclude a study in healthy volunteers.

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.

  • Phase 2 means the second implementation phase of this section, beginning June 1, 2022 and continuing thereafter.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Development Site means any parcel or lot on which exists or which is intended for building development other than the following:

  • Phase 2 Trial means a human clinical trial conducted on study subjects with the disease or condition being studied for the principal purpose of achieving a preliminary determination of efficacy or appropriate dosage ranges, as further described in 21 C.F.R. §312.21(b) (including any such clinical study in any country other than the United States).

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.

  • Annual Work Plan and Budget means the work plan and budget approved by the Bank and adopted by the Borrower in accordance with the provisions of Section I.C of Schedule 2 of this Agreement, as said work plan and budget may be modified from time to time with the written agreement of the Bank.

  • Project area budget means a multiyear projection of annual or cumulative

  • Redevelopment project means any work or undertaking

  • Phase 1 Trial means, with respect to a Licensed Product, a clinical trial (or — in case of a multi-phase clinical trial — those parts of a clinical trial) in line with the provisions of 21CFR312, Section 21 (a).